Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that is based on innovation and scientific rigor and integrity.
Our goal is to create novel products to meet critical patient needs, including:
1) Novel imaging-based diagnostic tools to improve the detection of occurrence, progression, and regression of neurological diseases; and
2) Novel therapies to improve the treatment of human neurological conditions.
Company Details
- Employees
- 21
- Founded
- 2015
- Phone
- +1-617-225-4415
- co****@****oia.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aprinoia.com
Aprinoia Therapeutics Questions
Aprinoia Therapeutics's helpline number is +1-617-225-4415
Aprinoia Therapeutics's website is aprinoia.com
Aprinoia Therapeutics's LinkedIn profile is https://www.linkedin.com/company/aprinoia-therapeutics
Aprinoia Therapeutics has
21 employees.
View email and phone details for 21
employees at Aprinoia Therapeutics.
Aprinoia Therapeutics's industry is
Biotechnology Research
Aprinoia Therapeutics's top competitors are
Blueprint Medicines,
Eli Lilly And Company,
Bicara Therapeutics,
Apogee Therapeutics,
Disc Medicine,
Seaport Therapeutics,
Cali Biosciences,
Ucb,
Par Clinical,
Immunovant.
Aprinoia Therapeutics's support email address is contact@aprinoia.com
Aprinoia Therapeutics's categories are Biotechnology Research
Aprinoia Therapeutics's founding year is 2015
